Detalhe da pesquisa
1.
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
J Allergy Clin Immunol
; 153(1): 203-215, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793571
2.
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111).
Int J Cancer
; 148(6): 1428-1437, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32930387
3.
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
Blood
; 126(1): 42-9, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918346
4.
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.
BMC Cancer
; 16: 21, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26772812